Related Experiment Videos
Coronary stenting for coronary artery disease in a cardiac transplant recipient
D K Murdock1, R W Murdock, D Lundberg
1Cardiovascular Associates of Northern Wisconsin, Wausau, USA.
Insights
Accelerated coronary artery disease is a major risk for heart transplant recipients. Coronary artery stenting, a common treatment for coronary artery disease, was successfully used in a heart transplant patient 11 years post-transplant.
Area of Science:
- Cardiology
- Transplantation Medicine
- Interventional Cardiology
Background:
- Accelerated coronary artery disease (ACAD) is the primary cause of mortality in heart transplant recipients.
- Existing treatments for ACAD in transplant patients often show limited efficacy.
- Coronary artery stenting is a standard intervention for coronary artery disease in non-transplant patients.
Observation:
- This case report focuses on a heart transplant recipient experiencing significant two-vessel coronary artery disease.
- The patient underwent orthotopic cardiac transplantation 11 years prior to this intervention.
- Few instances of utilizing coronary artery stenting in cardiac transplant recipients have been documented.
Findings:
- Successful application of coronary artery stenting in a heart transplant recipient with established ACAD.
- The intervention addressed significant two-vessel coronary artery disease.
- This approach was employed 11 years after the initial cardiac transplantation.
Implications:
- Coronary artery stenting may represent a viable therapeutic option for managing ACAD in heart transplant recipients.
- Further investigation into the long-term efficacy and safety of stenting for ACAD in this population is warranted.
- This case expands the evidence base for interventional cardiology techniques in post-transplant care.
Abstract:
Accelerated coronary artery disease in the transplanted heart remains the leading cause of death in heart transplant recipients. Traditional treatment modalities have generally yielded sub-optimal results. Coronary artery stents are used frequently in the non-transplanted heart to treat coronary artery disease. Only a few cases using this approach in the cardiac transplant recipient have been reported. This report details the use of this modality in a transplant recipient with significant two-vessel coronary artery disease 11 years after orthotopic cardiac transplantation.